This inventor holds 2 USPTO granted patents. Top assignees: Pelikan Technologies, Inc., Sanofi-A Ventis Deutschland Gmbh. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2009-2014
Title: Christoph Diekmann: Innovator in Blood Testing Technology
Introduction
Christoph Diekmann is a notable inventor based in Heidenheim, Germany. He has made significant contributions to the field of medical technology, particularly in blood testing apparatuses. With a total of 2 patents, Diekmann's innovations are paving the way for advancements in glucose monitoring systems.
Latest Patents
Diekmann's latest patents include a blood testing apparatus featuring a rotatable cartridge with multiple lancing elements and testing means. This innovative device incorporates a test member and a laser source designed to create a wound from which blood can flow. The laser source is capable of producing both a cutting wavelength and a coagulation wavelength. Additionally, the apparatus is equipped with electronics for analysis and a display, forming a comprehensive glucose monitoring system integrated into a single device. Another patent describes a blood testing apparatus that includes a device for withdrawing blood, a membrane-type testing element, an evaluating device, and a display device. This complete system can be manipulated as a single piece of apparatus, allowing for multiple testing elements to be inserted and used successively for various measurements.
Career Highlights
Throughout his career, Christoph Diekmann has worked with prominent companies such as Sanofi-Aventis Deutschland GmbH and Pelikan Technologies, Inc. His experience in these organizations has contributed to his expertise in developing innovative medical devices.
Collaborations
Diekmann has collaborated with notable individuals in his field, including Krzysztof Daniel Malowaniec and Thomas Wurster. These partnerships have likely enhanced his work and led to further advancements in blood testing technology.
Conclusion
Christoph Diekmann's contributions to blood testing technology demonstrate his commitment to innovation in the medical field. His patents reflect a deep understanding of the needs in glucose monitoring, and his career highlights showcase his collaboration with leading companies and professionals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile